Lycia Therapeutics, Inc. Common Stock (LYCA)
NMS · Healthcare · Biotechnology
$25.05
-4.06%
Closing price as of 2026-10-28 · Source: TEK2day Finance
Key Metrics
Annual Financials
| Metric | 2024-12-31 | 2025-12-31 |
|---|
| Revenue | 14.9M | 6.7M |
| Operating Income | (32.5M) | (39.9M) |
| Net Income | (26.5M) | (36.5M) |
Want live quotes, estimates, SEC filings, and CEO analytics for LYCA?
The free TEK2day terminal runs in your browser — type /LYCA to get started.
Open LYCA in the Terminal →